Valuation: Boryung Corporation

Market Cap 760B 538M 464M 436M 397M 746M 51.42B 756M 5.11B 2B 25.76B 2.02B 1.98B 85.69B P/E 2026 *
11.7x
P/E 2027 * 11.3x
Enterprise Value 760B 538M 464M 436M 397M 746M 51.42B 756M 5.11B 2B 25.76B 2.02B 1.98B 85.69B EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.7x
Free-Float
32.71%
Yield 2026 *
1.78%
Yield 2027 * 1.78%
1 day-1.85%
1 week-1.53%
Current month+9.89%
1 month+8.43%
3 months-7.22%
6 months-4.86%
Current year-0.11%
1 week 8,890
Extreme 8890
9,270
1 month 7,410
Extreme 7410
9,330
Current year 7,410
Extreme 7410
10,800
1 year 7,410
Extreme 7410
10,800
3 years 7,410
Extreme 7410
13,750
5 years 7,410
Extreme 7410
19,500
10 years 5,743.71
Extreme 5743.706919
25,083.33
Manager TitleAgeSince
Chief Executive Officer 41 2022-03-24
Director of Finance/CFO 51 -
Chief Tech/Sci/R&D Officer 55 -
Director TitleAgeSince
Director/Board Member 94 -
Chairman 68 2014-05-18
Director/Board Member 60 2022-03-24
Date Insider Type Main position Quantity % Market Cap.
6/12/25 Buy 117,572 0.1355%
6/12/25 Buy

Director

400,000 0.4609%
5/22/25 Buy

Responsable ventes & marketing

1,502 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%-1.53%+5.26%+0.56% 548M
-0.37%-3.44%+14.85%+65.22% 47.23B
+0.21%-4.14%+52.60%+119.23% 39.62B
-0.03%-2.18%-8.57%+15.75% 12.09B
-1.41%-6.33%+13.09%+72.20% 11.8B
+0.58%0.00%+30.65%+148.80% 9.12B
+0.15%-0.84%+22.33%+40.09% 7.57B
+1.33%+0.89%+42.84%-12.50% 7.1B
-1.03%+1.27%+16.77%+200.84% 6.87B
-0.97%-3.50%-30.77%+22.72% 5.81B
Average -0.41%-0.82%+15.91%+67.29% 14.78B
Weighted average by Cap. -0.20%-2.14%+23.88%+80.74%

Financials

2026 *2027 *
Net sales 1,058B 748M 646M 606M 552M 1.04B 71.53B 1.05B 7.1B 2.78B 35.84B 2.81B 2.75B 119B 1,084B 767M 662M 621M 566M 1.06B 73.32B 1.08B 7.28B 2.85B 36.73B 2.88B 2.82B 122B
Net income 66.2B 46.82M 40.42M 37.92M 34.54M 64.95M 4.48B 65.85M 445M 174M 2.24B 176M 172M 7.46B 68.2B 48.24M 41.64M 39.07M 35.58M 66.91M 4.61B 67.84M 458M 179M 2.31B 181M 177M 7.69B
Net Debt - -
Logo Boryung Corporation
Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.
Employees
1,533
Date Price Change Volume
26-08-17 9,000.00 -1.85% 96,812
26-08-14 ₩9,170.00 -0.11% 82,916
26-08-13 ₩9,180.00 -0.11% 85,668
26-08-12 ₩9,190.00 -0.43% 90,658
26-08-11 ₩9,230.00 +0.98% 131,665
Trader
-
Investor
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
9,170.00KRW
Average target price
14,000.00KRW
Spread / Average Target
+52.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A003850 Stock